News
Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...
Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...
Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
Semaglutide and tirzepatide prescriptions within Epic-affiliated health care systems increased slightly between 2021 and 2024, but ...
Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...
Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...
6d
Pharmaceutical Technology on MSNEli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketingMochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...
GLP-1s such as semaglutide and tirzepatide, originally formulated to treat patients with diabetes, have been touted as a solution for weight loss.
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results